Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

EOLS
Evolus, Inc. Common Stock
stock NASDAQ

At Close
Aug 7, 2026 3:59:57 PM EDT
7.58USD+2.294%(+0.17)1,630,865
0.00Bid   0.00Ask   0.00Spread
Pre-market
Aug 6, 2026 9:28:30 AM EDT
6.92USD-6.613%(-0.49)0
After-hours
Aug 7, 2026 4:00:30 PM EDT
7.44USD-1.847%(-0.14)193,074
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 27, 2022
05:01AM EST  41 Biggest Movers From Yesterday   Benzinga
Jan 26, 2022
08:46AM EST  Evolus Sees Prelim. Q2 Revenue $34.7M vs $30.87M Est.; Sees FY22 Sales $143M-$150M vs $144.96M Est.   Benzinga
Jan 20, 2022
10:41AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022   Benzinga
09:22AM EST  Truist Securities Upgrades Evolus to Buy, Announces $11 Price Target   Benzinga
Dec 20, 2021
08:46AM EST  Evolus Joins Nasdaq Biotechnology Index   Benzinga
Nov 9, 2021
08:30AM EST  Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating in two investment conferences in November.   GlobeNewswire Inc
Nov 3, 2021
09:14AM EDT  HC Wainwright & Co. Maintains Buy on Evolus, Lowers Price Target to $15   Benzinga
Nov 2, 2021
10:57AM EDT  Evolus Q3 EPS $(0.35) Misses $(0.27) Estimate, Sales $26.68M Beat $25.53M Estimate   Benzinga
10:57AM EDT  Evolus Initiates Phase II Program With "Extra Strength" Dose For Extended Duration   Benzinga
10:41AM EDT  Earnings Scheduled For November 2, 2021   Benzinga
08:03AM EDT  -- Record Quarter: U.S. Net Revenue Grew 58% Year-over-Year to $26.7 Million -- $107.8 Million Cash Position at Quarter-End -- Initiated Jeuveau Extra Strength Phase II Clinical Programto Demonstrate Extended Duration   GlobeNewswire Inc
08:01AM EDT  -- Program Designed to Offer Consumers an Extra Strength Dosing Option -- Evolus is Uniquely Positioned to Capitalize on this Opportunity with the CompanysAesthetics-Only Strategy and Jeuveau Product Precision -- First Patient Enrollment Expected in Q1 2022; Expected Completion in 1H 2023   GlobeNewswire Inc
Nov 1, 2021
04:10PM EDT  Evolus Announces Appointment of Jessica Novak as Senior Vice   GlobeNewswire Inc
Oct 22, 2021
09:00AM EDT  Evolus, Inc.(NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that it will report its third quarter 2021 financial results and provide a business update onTuesday, November 2, 2021, prior to the open of the U.S. financial markets.   GlobeNewswire Inc
Sep 2, 2021
09:00AM EDT  Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in two investment conferences in September.   GlobeNewswire Inc
Aug 23, 2021
04:29PM EDT  Medytox Discloses Purchase Of 103,000 Evolus Shares For $10.53/Share   Benzinga
Aug 4, 2021
05:11PM EDT  Evolus Q2 EPS $(0.31) Misses $(0.24) Estimate, Sales $26.10M Beat $24.67M Estimate   Benzinga
04:05PM EDT  Evolus Reports Second Quarter 2021 Results and Provides Business   GlobeNewswire Inc
04:10AM EDT  Earnings Scheduled For August 4, 2021   Benzinga
Jul 22, 2021
09:00AM EDT  Evolus, Inc.(NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its second quarter 2021 financial results and provide a business update onWednesday, August 4, 2021, after the close of the U.S. financial markets.   GlobeNewswire Inc
Jun 30, 2021
09:00AM EDT  Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that David K. Erickson has joined the company as Vice President, Investor Relations where he will be responsible for developing, implementing and managing a comprehensive and strategic investor relations program.   GlobeNewswire Inc
Jun 24, 2021
09:06AM EDT  Evolus Highlights Peer-Reviewed Article On Efficacy, Safety Of Its Jeuveau In Patients With Skin Of Color   Benzinga
09:00AM EDT  Peer Reviewed Article Highlights Efficacy and Safety of   GlobeNewswire Inc
May 19, 2021
09:00AM EDT  Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced the appointment of Dan Stewart as Vice President and General Manager of the companys International business.   GlobeNewswire Inc
May 18, 2021
12:16PM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2021   Benzinga
May 13, 2021
07:39AM EDT  Barclays Maintains Underweight on Evolus, Lowers Price Target to $7   Benzinga
May 12, 2021
04:42PM EDT  Evolus Says On Track For $100M Annual Net Revenue Run Rate In Q2 2021   Benzinga
04:41PM EDT  Evolus Q1 EPS $(0.44) Misses $(0.43) Estimate, Sales $12.24M Beat $11.67M Estimate   Benzinga
04:05PM EDT  Evolus Reports First Quarter 2021 Results and Provides Business Update   GlobeNewswire Inc
10:33AM EDT  Repeat Doses Of Evolus' Frown Lines Treatment Are Safe, With Decreasing Rates Of Adverse Events   Benzinga
09:11AM EDT  Evolus Highlights Aesthetic Surgery Journal Publication Of Long Term Safety And Efficacy Data Of Jeuveau For Treatment Of Moderate To Severe Frown Lines   Benzinga
09:00AM EDT  Aesthetic Surgery Journal Publishes Long Term Safety and Efficacy   GlobeNewswire Inc
04:22AM EDT  Earnings Scheduled For May 12, 2021   Benzinga
May 6, 2021
01:47PM EDT  Evolus shares were trading higher after Mizuho upgraded the stock from Neutral to Buy and announced a price target of $15 per share.   Benzinga
10:06AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2021   Benzinga
06:36AM EDT  Mizuho Upgrades Evolus to Buy, Announces $15 Price Target   Benzinga
May 4, 2021
04:05PM EDT  Evolus, Inc.(NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its first quarter 2021 financial results and provide a business update onWednesday, May 12, 2021, after the close of the U.S. financial markets.   GlobeNewswire Inc
Apr 22, 2021
02:40PM EDT  Mid-Afternoon Market Update: Dow Falls 300 Points; Teradata Shares Spike Higher   Benzinga
12:20PM EDT  Mid-Day Market Update: Qualtrics International Jumps After Q1 Results; Evolus Shares Slide   Benzinga
10:18AM EDT  Mid-Morning Market Update: Markets Down; AT&T Tops Q1 Views   Benzinga
08:09AM EDT  The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs   Benzinga
05:43AM EDT  Evolus Priced 9M Share Public Offering of Common Stock @$9.50/Share   Benzinga
Apr 21, 2021
04:02PM EDT  Evolus Announces A Proposed Common Stock Offering; No Terms Disclosed   Benzinga
04:01PM EDT  Evolus Announces Proposed Public Offering of Common Stock   GlobeNewswire Inc
Apr 8, 2021
03:23PM EDT  Evolus shares were trading higher after HC Wainwright & Co reiterated its Buy rating and raised its price target from $20 to $22 per share.   Benzinga
06:27AM EDT  HC Wainwright & Co. Reiterates Buy on Evolus, Raises Price Target to $22   Benzinga
Mar 25, 2021
02:39PM EDT  Mid-Afternoon Market Update: Dow Rises 75 Points; Rite Aid Shares Plummet   Benzinga
12:08PM EDT  Mid-Day Market Update: Crude Oil Down Over 4%; Cellect Biotechnology Shares Surge   Benzinga
Mar 24, 2021
04:12PM EDT  Evolus Q4 EPS $(3.28) Down From $(0.47) YoY, Sales $20.58M Miss $21.20M Estimate   Benzinga
04:05PM EDT  Q4 2020 Net Revenue $20.6 Million, Highest Net Revenue Quarter Since Launch of Jeuveau   GlobeNewswire Inc
06:35AM EDT  HC Wainwright & Co. Maintains Buy on Evolus, Raises Price Target to $20   Benzinga
04:29AM EDT  Earnings Scheduled For March 24, 2021   Benzinga
Mar 23, 2021
01:52PM EDT  Daewoong Pharmaceutical Injects More Liquidity In Evolus   Benzinga
09:21AM EDT  Evolus, Inc.(NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its fourth quarter and year end 2020 financial results and provide a business update conference call and live audio webcast onWednesday, March 24, 2021.   GlobeNewswire Inc
09:20AM EDT  Evolus Announces $25.5M Cash Infusion From Daewoong Pharmaceutical Co., Announces Elimination Of $127.4M In Debt And Milestone Payments   Benzinga
09:18AM EDT  Evolus Strengthens Balance Sheet Through a $25.5 Million Cash   GlobeNewswire Inc
Mar 2, 2021
04:05PM EST  Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in two upcoming virtual investor conferences.   GlobeNewswire Inc
10:06AM EST  Shares of Evolus Inc. (EOLS) are currently trading at $13.77, up $1.26 or 10.07% with trading volume rising over 309K versus an average volume of 1.50 million shares. The stock has been trading between $2.85 and $14.81 for the past one year.   RTTNews
Feb 26, 2021
09:04AM EST  Evolus Names New Chief Marketing Officer   Benzinga
09:00AM EST  Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced the promotion of Crystal Muilenburg from VP, Corporate Communications & PR to Chief Marketing Officer effective today.   GlobeNewswire Inc
Feb 24, 2021
11:30AM EST  Truist Securities Downgrades Evolus to Hold, Raises Price Target to $12   Benzinga
Feb 23, 2021
09:11AM EST  Evolus Q4 Net Sales $20.6M; FY20 Net Sales $56.5M   Benzinga
09:00AM EST  Evolus, Inc. (NASDAQ: EOLS) today announced its preliminary, unaudited, net revenues for the fourth quarter and full year ended December 31, 2020. The preliminary unaudited results described in this press release are estimates only and are subject to revision until the company reports its full financial results for the fourth quarter and full year 2020.   GlobeNewswire Inc
Feb 22, 2021
07:59AM EST  10 Biggest Price Target Changes For Monday   Benzinga
06:25AM EST  HC Wainwright & Co. Maintains Buy on Evolus, Raises Price Target to $18   Benzinga
Feb 19, 2021
04:05PM EST  Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in the 10th Annual SVB Leerink Global Healthcare Conference.   GlobeNewswire Inc
02:36PM EST  Mid-Afternoon Market Update: S&P 500 Turns Negative; Vaccinex Shares Spike Higher   Benzinga
12:27PM EST  Mid-Day Market Update: JMP Group Jumps After Q4 Earnings; PDF Solutions Shares Plummet   Benzinga
10:42AM EST  Evolus Shares Surge After Settling Jeuveau Related Litigation With AbbVie, Medytox   Benzinga
10:36AM EST  Shares of medical aesthetic products maker Evolus, Inc. (EOLS) are up more than 50% Friday morning following the company's settlement agreement with AbbVie, and Medytox.   RTTNews
10:15AM EST  Mid-Morning Market Update: Markets Open Higher; Deere Beats Q4 Expectations   Benzinga
09:31AM EST  AbbVie (ABBV), Evolus (EOLS) and Medytox have reached settlement agreements to fully resolve all outstanding litigation, including the United States International Trade Commission or ITC case regarding the sale of Jeuveau, between the companies. A California court case filed by Medytox against Evolus will be dismissed.   RTTNews
09:17AM EST  AbbVie, Evolus And Medytox Announce Settlement Agreements To Fully Resolve All Outstanding Litigation   RTTNews
09:15AM EST  AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property   PR Newswire
Dec 17, 2020
08:10AM EST  The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut   Benzinga
Dec 16, 2020
05:45PM EST  Evolus Provides Update on United States International Trade   GlobeNewswire Inc
Dec 15, 2020
09:27AM EST  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Evolus, Inc. (NASDAQ: EOLS) between February 1, 2019 and July 6, 2020, inclusive (the Class Period), of the important December 15, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Evolus investors under the federal securities laws.   GlobeNewswire Inc
Dec 14, 2020
01:00PM EST  DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming   PR Newswire
11:00AM EST  EOLS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Evolus, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 15, 2020   Business Wire
11:00AM EST  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
08:00AM EST  The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Evolus, Inc. (NASDAQ:EOLS) investors that acquired shares between February 1, 2019 and July 6, 2020. Investors have until December 15, 2020 to seek an active role in this litigation.   GlobeNewswire Inc
Dec 11, 2020
09:00PM EST  DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That   GlobeNewswire Inc
Dec 10, 2020
05:00PM EST  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Evolus, Inc. (NASDAQ: EOLS) between February 1, 2019 and July 6, 2020, inclusive (the Class Period), of the important December 15, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Evolus investors under the federal securities laws.   GlobeNewswire Inc
Dec 9, 2020
12:00PM EST  Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming December 15, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Evolus, Inc.(Evolus or the Company) (NASDAQ: EOLS) securities between February 1, 2019 and July 6, 2020, inclusive (the Class Period).   GlobeNewswire Inc
11:59AM EST  SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Reminds Investors of   GlobeNewswire Inc
11:00AM EST  RETA, EOLS & TRQ Class Actions: Bronstein, Gewirtz & Grossman LLC   GlobeNewswire Inc
Dec 8, 2020
11:15AM EST  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Dec 7, 2020
12:30PM EST  Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Dec 4, 2020
08:00AM EST  Investors with losses in excess of $1,000,000 are encouraged to contact the firm before December 15, 2020; click here to submit trade information   GlobeNewswire Inc
Dec 3, 2020
05:29PM EST  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Evolus, Inc. (NASDAQ: EOLS) between February 1, 2019 and July 6, 2020, inclusive (the Class Period), of the important December 15, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Evolus investors under the federal securities laws.   GlobeNewswire Inc
04:10AM EST  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their   PR Newswire
Dec 2, 2020
05:00PM EST  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action   GlobeNewswire Inc
Dec 1, 2020
11:58PM EST  December 15 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - EOLS   PR Newswire
04:35PM EST  INVESTOR ALERT: Kirby McInerney LLP Reminds Investors of   GlobeNewswire Inc
11:15AM EST  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
11:00AM EST  Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Nov 30, 2020
10:50PM EST  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with   GlobeNewswire Inc
Nov 25, 2020
08:21PM EST  Investors with losses in excess of $1,000,000 are encouraged to contact the firm before December 15, 2020; click here to submit trade information   GlobeNewswire Inc
06:28AM EST  SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Reminds Investors of a   GlobeNewswire Inc
Nov 24, 2020
05:51PM EST  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Evolus, Inc. (NASDAQ: EOLS) between February 1, 2019 and July 6, 2020, inclusive (the Class Period), of the important December 15, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Evolus investors under the federal securities laws.   GlobeNewswire Inc
05:00PM EST  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action   GlobeNewswire Inc
04:00PM EST  reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased Evolus, Inc.   PR Newswire
10:45AM EST  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Nov 22, 2020
01:45AM EST  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with   GlobeNewswire Inc
Nov 21, 2020
01:07PM EST  LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors with Losses   PR Newswire
Nov 20, 2020
04:46PM EST  INVESTOR ALERT: Kirby McInerney LLP Reminds Investors of   GlobeNewswire Inc
Nov 19, 2020
12:30PM EST  Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
11:45AM EST  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Nov 18, 2020
06:00PM EST  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action   GlobeNewswire Inc
02:10PM EST  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Evolus, Inc. (NASDAQ: EOLS) between February 1, 2019 and July 6, 2020, inclusive (the Class Period), of the important December 15, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Evolus investors under the federal securities laws.   GlobeNewswire Inc
Nov 16, 2020
11:00AM EST  Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming December 15, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Evolus, Inc.(Evolus or the Company) (NASDAQ: EOLS) securities between February 1, 2019 and July 6, 2020, inclusive (the Class Period).   GlobeNewswire Inc
Nov 14, 2020
03:40PM EST  ROSEN, A TOP RANKED LAW FIRM, Reminds Evolus, Inc. Investors of Important   PR Newswire
Nov 13, 2020
06:04PM EST  INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class   GlobeNewswire Inc
Nov 12, 2020
02:46PM EST  EVOLUS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman &   GlobeNewswire Inc
02:00AM EST  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with   GlobeNewswire Inc
Nov 11, 2020
07:30PM EST  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Evolus, Inc. (NASDAQ: EOLS) between February 1, 2019 and July 6, 2020, inclusive (the Class Period), of the important December 15, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Evolus investors under the federal securities laws.   GlobeNewswire Inc
06:00PM EST  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action   GlobeNewswire Inc
12:30PM EST  Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
11:00AM EST  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
Nov 9, 2020
12:01PM EST  DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming   PR Newswire
Nov 8, 2020
02:20AM EST  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with   GlobeNewswire Inc
Nov 5, 2020
12:30PM EST  Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class   PR Newswire
Nov 3, 2020
11:31AM EST  The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class   PR Newswire
Nov 2, 2020
11:00AM EST  EOLS Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds   GlobeNewswire Inc
Oct 30, 2020
08:37PM EDT  Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - EOLS   PR Newswire
12:02PM EDT  The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.   GlobeNewswire Inc
09:01AM EDT  announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased Evolus, Inc.   PR Newswire
08:09AM EDT  The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts   Benzinga
Oct 29, 2020
05:00PM EDT  Evolus Q3 EPS $(0.34) Up From $(0.98) YoY, Sales $17.70M Up From $13.17M YoY   Benzinga
Oct 28, 2020
11:00AM EDT  EOLS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Evolus, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 15, 2020   Business Wire
Oct 26, 2020
07:54PM EDT  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with   GlobeNewswire Inc
Oct 22, 2020
02:48PM EDT  EVOLUS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman &   GlobeNewswire Inc
11:00AM EDT  EOLS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies   GlobeNewswire Inc
Oct 21, 2020
08:45PM EDT  Lawsuit Against Evolus, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - EOLS   PR Newswire
05:37PM EDT  Pomerantz Law Firm Announces the Filing of a Class Action against Evolus, Inc.   PR Newswire
Oct 20, 2020
04:23PM EDT  Gainey McKenna & Egleston Announces A ClassAction   GlobeNewswire Inc
11:00AM EDT  EOLS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Evolus, Inc.   PR Newswire
Oct 19, 2020
08:00PM EDT  EVOLUS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class   GlobeNewswire Inc
06:21PM EDT  INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a   GlobeNewswire Inc
11:51AM EDT  Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Evolus, Inc. (Evolus or the Company) (NASDAQ: EOLS) to determine whether the Company engaged in securities fraud or other unlawful business practices.   GlobeNewswire Inc
Oct 16, 2020
05:18PM EDT  SHAREHOLDER ALERT: Lowey Dannenberg Files Securities Class Action   GlobeNewswire Inc
Oct 9, 2020
09:00PM EDT  Bragar Eagel & Squire, P.C. Is Investigating Evolus, Lizhi,   GlobeNewswire Inc
Sep 15, 2020
07:43PM EDT  The Portnoy Law Firm advises Evolus, Inc. ("Evolus" or the "Company") (NASDAQ: EOLS) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.   GlobeNewswire Inc
01:50PM EDT  The law firm of Kirby McInerney LLP is investigating potential claims against Evolus, Inc. (Evolus or the Company) (NASDAQ: EOLS). The investigation focuses on whether whether Evolus has violated the federal securities laws and/or engaged in other unlawful business practices.   GlobeNewswire Inc
Sep 14, 2020
06:00PM EDT  Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Evolus, Inc. (NASDAQ: EOLS) on behalf of Evolus stockholders. Our investigation concerns whether Evolus has violated the federal securities laws and/or engaged in other unlawful business practices.   GlobeNewswire Inc
Sep 8, 2020
08:30AM EDT  Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in three upcoming virtual investor conferences.   GlobeNewswire Inc
Sep 3, 2020
10:47AM EDT  Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors is investigating possible violations of federal securities laws on behalf of investors of Evolus, Inc. (Evolus or the Company) (NASDAQ: EOLS).   GlobeNewswire Inc
Aug 11, 2020
11:26AM EDT  HC Wainwright & Co. Maintains Buy on Evolus, Raises Price Target to $8   Benzinga
Aug 10, 2020
04:32PM EDT  Evolus Q2 EPS $(0.63) Beats $(0.70) Estimate, Sales $7.80M May Not Compare To $2.12M Estimate   Benzinga
04:05PM EDT  Evolus Reports Second Quarter 2020 Results and Provides Business   GlobeNewswire Inc
04:10AM EDT  Earnings Scheduled For August 10, 2020   Benzinga
Aug 7, 2020
11:09AM EDT  Earnings Outlook For Evolus   Benzinga
Jul 27, 2020
04:01PM EDT  Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced today that it will report its second quarter 2020 financial results and provide a business update on Monday, August 10, 2020 after the close of the U.S. financial markets.   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC